Command Palette

Search for a command to run...

Clinical Trials · NCT00603109

Effect of Rimonabant on Weight Gain and Body Composition in Adults With Prader Willi Syndrome

TerminatedPhase 3Ghrp-6 (Prohibited)
Phase
Phase 3
Recruitment status
Terminated
Sponsor
Weill Medical College of Cornell University
Enrollment
10
Start date
Aug 2007
Locations
1 site, United States
Primary endpoint
Body Weight and Body fat mass
View Ghrp-6 compound reference